U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C10H12F3N
Molecular Weight 203.2042
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NORFENFLURAMINE

SMILES

CC(N)CC1=CC=CC(=C1)C(F)(F)F

InChI

InChIKey=MLBHFBKZUPLWBD-UHFFFAOYSA-N
InChI=1S/C10H12F3N/c1-7(14)5-8-3-2-4-9(6-8)10(11,12)13/h2-4,6-7H,5,14H2,1H3

HIDE SMILES / InChI

Molecular Formula C10H12F3N
Molecular Weight 203.2042
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 09:53:13 UTC 2023
Edited
by admin
on Sat Dec 16 09:53:13 UTC 2023
Record UNII
037A9J3PSW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NORFENFLURAMINE
Common Name English
JP-92
Common Name English
DL-NORFENFLURAMINE
Common Name English
NSC-43036
Code English
BENZENEETHANAMINE, .ALPHA.-METHYL-3-(TRIFLUOROMETHYL)-
Systematic Name English
2-AMINO-1-(3-(TRIFLUOROMETHYL)PHENYL)PROPANE
Systematic Name English
DESETHYLFENFLURAMINE
Common Name English
(±)-2-AMINO-1-(3'-TRIFLUOROMETHYLPHENYL)PROPANE
Common Name English
(±)-NORFENFLURAMINE
Common Name English
.ALPHA.-METHYL-3-(TRIFLUOROMETHYL)BENZENEETHANAMINE
Systematic Name English
1-(M-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE
Systematic Name English
Code System Code Type Description
CAS
1886-26-6
Created by admin on Sat Dec 16 09:53:14 UTC 2023 , Edited by admin on Sat Dec 16 09:53:14 UTC 2023
PRIMARY
NSC
43036
Created by admin on Sat Dec 16 09:53:14 UTC 2023 , Edited by admin on Sat Dec 16 09:53:14 UTC 2023
PRIMARY
EPA CompTox
DTXSID60904717
Created by admin on Sat Dec 16 09:53:14 UTC 2023 , Edited by admin on Sat Dec 16 09:53:14 UTC 2023
PRIMARY
PUBCHEM
15897
Created by admin on Sat Dec 16 09:53:14 UTC 2023 , Edited by admin on Sat Dec 16 09:53:14 UTC 2023
PRIMARY
FDA UNII
037A9J3PSW
Created by admin on Sat Dec 16 09:53:14 UTC 2023 , Edited by admin on Sat Dec 16 09:53:14 UTC 2023
PRIMARY
WIKIPEDIA
Norfenfluramine
Created by admin on Sat Dec 16 09:53:14 UTC 2023 , Edited by admin on Sat Dec 16 09:53:14 UTC 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
OFF-TARGET->AGONIST
We propose that preferential stimulation of valvular 5-HT2B receptors by norfenfluramine, ergot drugs, or 5-HT released from carcinoid tumors (with or without accompanying 5-HT2A receptor activation) may contribute to valvular fibroplasia in humans.
Ki
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> METABOLITE TOXIC
Responsible for
MAJOR
PARENT -> METABOLITE
Metabolite to parent drug ratio in non-uraemic human plasma. A positive correlation exists between plasma norfenfluramine levels and weight loss in man.
METABOLITE TO PARENT DRUG RATIO
PLASMA; URINE
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC